Literature DB >> 3361658

Monotherapy of staghorn renal calculi: a comparative study between percutaneous nephrolithotomy and extracorporeal shock wave lithotripsy.

H N Winfield1, R V Clayman, C G Chaussy, P J Weyman, G J Fuchs, A N Lupu.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3361658     DOI: 10.1016/s0022-5347(17)42709-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  7 in total

1.  Strategic lithotripsy using the Doli S EMSE 220 F-XP for the management of staghorn renal calculi.

Authors:  Ioannis Heretis; Charalampos Mamoulakis; Vaios Papadimitriou; Frank Sofras
Journal:  Int Urol Nephrol       Date:  2010-06-08       Impact factor: 2.370

2.  Effect of extracorporeal shock wave lithotripsy on bacterial viability. Relationship to the treatment of struvite stones.

Authors:  G Reid; M A Jewett; J C Nickel; R J McLean; A W Bruce
Journal:  Urol Res       Date:  1990

3.  Treatment of Renal Calculi with Extracorporeal Shock Wave Lithotripsy: How applications of this method have expanded.

Authors:  P M Eberwein; J D Denstedt
Journal:  Can Fam Physician       Date:  1992-07       Impact factor: 3.275

4.  The necessity of prophylactic antibiotics during extracorporeal shock wave lithotripsy.

Authors:  C Deliveliotis; A Giftopoulos; G Koutsokalis; G Raptidis; A Kostakopoulos
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

5.  Experience with extracorporeal shock-wave lithotripsy (ESWL) for urinary calculi.

Authors:  S Dutkiewicz; K Debski; A Witoska; P Woszczyk; Z Pawluczuk
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 6.  The recurrence rate of stones following ESWL.

Authors:  K U Köhrmann; J Rassweiler; P Alken
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

7.  Open stone surgery: is it still a preferable procedure in the management of staghorn calculi?

Authors:  A A Esen; Z Kirkali; C Güler
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.